Evidence to support use of palonosetron over generic serotonin type 3–receptor antagonists for chemotherapy-induced nausea and vomiting-Reference-Cited by-同舟云学术

Evidence to support use of palonosetron over generic serotonin type 3–receptor antagonists for chemotherapy-induced nausea and vomiting

Published:2014-03-15 Issue:6 Volume:71 Page:500-506
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Yeh Yu-Chen¹,Blouin Gayle C.²,Reddy Prabashni³

Affiliation:

1. Center for Drug Policy, Partners Healthcare, Needham, MA.

2. Yawkey Center for Outpatient Care, Massachusetts General Hospital, Boston.

3. Center for Drug Policy, Partners Healthcare

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/71/6/500/28372339/ajhp0500.pdf

Reference41 articles.

1. Antiemetics: American Society of Clinical Oncology clinical practice guideline update;Basch;J Clin Oncol,2011

2. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Antiemetics, version 1. 2014. Available from www.nccn.org.

3. Guideline update for MASCC and ESMO in the prevention of chemotherapy and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference;Roila;Ann Oncol,2010

4. Centers for Medicare and Medicaid Services. ASP drug pricing files, January 2013 update. www.cms.gov/Medicare/Medicare-Fee-for-Service-Part-B-Drugs/McrPartBDrugAvgSalesPrice/2013ASPFiles.html (accessed 2012 Dec 7).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Antiemetics;Cancer Nursing;2019-01-26

2. Real-world efficacy: intravenous palonosetron three-drug regimen for chemotherapy-induced nausea and vomiting with highly emetogenic chemotherapy;Journal of Comparative Effectiveness Research;2018-12

3. Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients;Pediatric Drugs;2017-04-21

4. Complications of Opioid Therapy;Controlled Substance Management in Chronic Pain;2016

5. Palonosetron in the management of chemotherapy- induced nausea and vomiting in patients receiving multiple-day chemotherapy;Cancer Management and Research;2014-09